145 related articles for article (PubMed ID: 38900651)
1. Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J; Bartha G; Harris J; Li C; Navarro FCP; Pyke RM; Hong M; Zhang Q; Ma S; Chen TX; Lai J; Udar N; Saldivar JS; Ayash E; Anderson J; Li J; Cui T; Le T; Chow R; Velasco RJ; Mallo C; Santiago R; Bruce RC; Goodman LJ; Chen Y; Norton D; Chen RO; Lyle JM
Oncotarget; 2024 Jun; 15():407. PubMed ID: 38900651
[No Abstract] [Full Text] [Related]
2. Clinical testing should be individualized, not based on populations.
Walt DR
J Clin Invest; 2019 Sep; 129(9):3472-3473. PubMed ID: 31478913
[No Abstract] [Full Text] [Related]
3. Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J; Bartha G; Harris J; Li C; Navarro FCP; Pyke RM; Hong M; Zhang Q; Ma S; Chen TX; Lai J; Udar N; Saldivar JS; Ayash E; Anderson J; Li J; Cui T; Le T; Chow R; Velasco RJ; Mallo C; Santiago R; Bruce RC; Goodman LJ; Chen Y; Norton D; Chen RO; Lyle JM
Oncotarget; 2024 Mar; 15():200-218. PubMed ID: 38484152
[TBL] [Abstract][Full Text] [Related]
4. Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection.
Ococks E; Sharma S; Ng AWT; Aleshin A; Fitzgerald RC; Smyth E
Gastroenterology; 2021 Nov; 161(5):1705-1708.e2. PubMed ID: 34284036
[No Abstract] [Full Text] [Related]
5. Liquid Biopsy and Lung Cancer.
Pisapia P; Malapelle U; Troncone G
Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
[TBL] [Abstract][Full Text] [Related]
6. Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.
Vellichirammal NN; Chaturvedi NK; Joshi SS; Coulter DW; Guda C
Cancer Lett; 2021 Feb; 499():24-38. PubMed ID: 33248210
[TBL] [Abstract][Full Text] [Related]
7. Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients.
Palmieri M; Baldassarri M; Fava F; Fabbiani A; Gelli E; Tita R; Torre P; Petrioli R; Hadijstilianou T; Galimberti D; Cinotti E; Bengala C; Mandalà M; Piu P; Miano ST; Martellucci I; Vannini A; Pinto AM; Mencarelli MA; Marsili S; Renieri A; Frullanti E
Cancer Med; 2020 Mar; 9(6):2052-2061. PubMed ID: 31991072
[TBL] [Abstract][Full Text] [Related]
8. Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.
Coombes RC; Page K; Salari R; Hastings RK; Armstrong A; Ahmed S; Ali S; Cleator S; Kenny L; Stebbing J; Rutherford M; Sethi H; Boydell A; Swenerton R; Fernandez-Garcia D; Gleason KLT; Goddard K; Guttery DS; Assaf ZJ; Wu HT; Natarajan P; Moore DA; Primrose L; Dashner S; Tin AS; Balcioglu M; Srinivasan R; Shchegrova SV; Olson A; Hafez D; Billings P; Aleshin A; Rehman F; Toghill BJ; Hills A; Louie MC; Lin CJ; Zimmermann BG; Shaw JA
Clin Cancer Res; 2019 Jul; 25(14):4255-4263. PubMed ID: 30992300
[TBL] [Abstract][Full Text] [Related]
9. Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.
Ziogas DE; Kyrochristos ID; Lykoudis EG; Roukos DH
Biomark Med; 2018 Nov; 12(11):1197-1201. PubMed ID: 30379093
[No Abstract] [Full Text] [Related]
10. Circulating tumor DNA-From bench to bedside.
Lim JSJ; Janku F; Yap TA
Curr Probl Cancer; 2017; 41(3):212-221. PubMed ID: 28416241
[TBL] [Abstract][Full Text] [Related]
11. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
[TBL] [Abstract][Full Text] [Related]
12. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.
George SL; Izquierdo E; Campbell J; Koutroumanidou E; Proszek P; Jamal S; Hughes D; Yuan L; Marshall LV; Carceller F; Chisholm JC; Vaidya S; Mandeville H; Angelini P; Wasti A; Bexelius T; Thway K; Gatz SA; Clarke M; Al-Lazikani B; Barone G; Anderson J; Tweddle DA; Gonzalez D; Walker BA; Barton J; Depani S; Eze J; Ahmed SW; Moreno L; Pearson A; Shipley J; Jones C; Hargrave D; Jacques TS; Hubank M; Chesler L
Eur J Cancer; 2019 Nov; 121():224-235. PubMed ID: 31543384
[TBL] [Abstract][Full Text] [Related]
13. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing.
Guan Y; Mayba O; Sandmann T; Lu S; Choi Y; Darbonne WC; Leveque V; Ryner L; Humke E; Tam NWR; Sujathasarma S; Cheung A; Bourgon R; Lackner MR; Wang Y
J Mol Diagn; 2017 Nov; 19(6):921-932. PubMed ID: 28867605
[TBL] [Abstract][Full Text] [Related]
15. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
Zugazagoitia J; Ramos I; Trigo JM; Palka M; Gómez-Rueda A; Jantus-Lewintre E; Camps C; Isla D; Iranzo P; Ponce-Aix S; García-Campelo R; Provencio M; Franco F; Bernabé R; Juan-Vidal O; Felip E; de Castro J; Sanchez-Torres JM; Faul I; Lanman RB; Garrido P; Paz-Ares L
Ann Oncol; 2019 Feb; 30(2):290-296. PubMed ID: 30535340
[TBL] [Abstract][Full Text] [Related]
17. New cancer blood test developed.
Burki TK
Lancet Oncol; 2018 Mar; 19(3):e140. PubMed ID: 29395866
[No Abstract] [Full Text] [Related]
18. Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.
Batth IS; Mitra A; Manier S; Ghobrial IM; Menter D; Kopetz S; Li S
Ann Oncol; 2017 Mar; 28(3):468-477. PubMed ID: 27998963
[TBL] [Abstract][Full Text] [Related]
19. Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA.
Frydendahl A; Rasmussen MH; Jensen SØ; Henriksen TV; Demuth C; Diekema M; Ditzel HJ; Wen SWC; Pedersen JS; Dyrskjøt L; Andersen CL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673836
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation.
Liu SC
World J Gastroenterol; 2024 Apr; 30(15):2175-2178. PubMed ID: 38681986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
